Combination Therapies 2: Biological Response Modifiers in the Treatment of Cancer and Infectious Diseases
The 2nd International Symposium on Combination Therapies brought together several hundred of the leading researchers, scientists and clinicians in this area to discuss new and emerging uses for biological response modifiers (BRM's) in the treatment of cancer and infectious diseases. The meeting...
Gespeichert in:
| Weitere Verfasser: | , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Boston, MA
Springer US
1993
|
| Schlagworte: | |
| Online-Zugang: | UBR01 Volltext |
| Zusammenfassung: | The 2nd International Symposium on Combination Therapies brought together several hundred of the leading researchers, scientists and clinicians in this area to discuss new and emerging uses for biological response modifiers (BRM's) in the treatment of cancer and infectious diseases. The meeting was held during May 1-3, 1992 in Acireale, Sicily (Italy). It was hosted by Professor G. Nicoletti CU. of Catania) and organized by the Institute for Advanced Studies in Immunology and Aging (Washington, D. C. ) in collaboration with the University of Rome "Tor Vergata," the University of Catania and The George Washington University Medical Center. The synergy exhibited between BRM's and conventional therapies including bone marrow and other lymphoid cell transplants is a rapidly expanding area with significant promise for the treatment of human diseases. Advances in this area of biomedicine are leading to the rapid development of new therapeutic approaches that are being applied clinically as both primary and adjuvant therapy to enhance the effectiveness of conventional treatments. The 2nd International Symposium on Combination Therapy provided a setting for the exchange of new scientific information regarding the emerging uses for BRM's alone or in combination with conventional therapies. The 1st International Symposium on Combination Therapies was held in 1991 in Washington, D. C. |
| Beschreibung: | 1 Online-Ressource (X, 256 p) |
| ISBN: | 9781461529644 |
| DOI: | 10.1007/978-1-4615-2964-4 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV046146396 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 190905s1993 |||| o||u| ||||||eng d | ||
| 020 | |a 9781461529644 |9 978-1-4615-2964-4 | ||
| 024 | 7 | |a 10.1007/978-1-4615-2964-4 |2 doi | |
| 035 | |a (ZDB-2-SME)978-1-4615-2964-4 | ||
| 035 | |a (OCoLC)1119090581 | ||
| 035 | |a (DE-599)BVBBV046146396 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 082 | 0 | |a 616.9 |2 23 | |
| 245 | 1 | 0 | |a Combination Therapies 2 |b Biological Response Modifiers in the Treatment of Cancer and Infectious Diseases |c edited by Enrico Garaci, Allan L. Goldstein |
| 264 | 1 | |a Boston, MA |b Springer US |c 1993 | |
| 300 | |a 1 Online-Ressource (X, 256 p) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 520 | |a The 2nd International Symposium on Combination Therapies brought together several hundred of the leading researchers, scientists and clinicians in this area to discuss new and emerging uses for biological response modifiers (BRM's) in the treatment of cancer and infectious diseases. The meeting was held during May 1-3, 1992 in Acireale, Sicily (Italy). It was hosted by Professor G. Nicoletti CU. of Catania) and organized by the Institute for Advanced Studies in Immunology and Aging (Washington, D. C. ) in collaboration with the University of Rome "Tor Vergata," the University of Catania and The George Washington University Medical Center. The synergy exhibited between BRM's and conventional therapies including bone marrow and other lymphoid cell transplants is a rapidly expanding area with significant promise for the treatment of human diseases. Advances in this area of biomedicine are leading to the rapid development of new therapeutic approaches that are being applied clinically as both primary and adjuvant therapy to enhance the effectiveness of conventional treatments. The 2nd International Symposium on Combination Therapy provided a setting for the exchange of new scientific information regarding the emerging uses for BRM's alone or in combination with conventional therapies. The 1st International Symposium on Combination Therapies was held in 1991 in Washington, D. C. | ||
| 650 | 4 | |a Infectious Diseases | |
| 650 | 4 | |a Immunology | |
| 650 | 4 | |a Pharmacology/Toxicology | |
| 650 | 4 | |a Emerging infectious diseases | |
| 650 | 4 | |a Immunology | |
| 650 | 4 | |a Toxicology | |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 700 | 1 | |a Garaci, Enrico |4 edt | |
| 700 | 1 | |a Goldstein, Allan L. |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9780306445897 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781461362890 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781461529651 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-1-4615-2964-4 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-SME | ||
| 940 | 1 | |q ZDB-2-SME_1990/2004 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-031526581 | ||
| 966 | e | |u https://doi.org/10.1007/978-1-4615-2964-4 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804180484319608832 |
|---|---|
| any_adam_object | |
| author2 | Garaci, Enrico Goldstein, Allan L. |
| author2_role | edt edt |
| author2_variant | e g eg a l g al alg |
| author_facet | Garaci, Enrico Goldstein, Allan L. |
| building | Verbundindex |
| bvnumber | BV046146396 |
| collection | ZDB-2-SME |
| ctrlnum | (ZDB-2-SME)978-1-4615-2964-4 (OCoLC)1119090581 (DE-599)BVBBV046146396 |
| dewey-full | 616.9 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.9 |
| dewey-search | 616.9 |
| dewey-sort | 3616.9 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| doi_str_mv | 10.1007/978-1-4615-2964-4 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03135nmm a2200481zc 4500</leader><controlfield tag="001">BV046146396</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s1993 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781461529644</subfield><subfield code="9">978-1-4615-2964-4</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-1-4615-2964-4</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-1-4615-2964-4</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1119090581</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046146396</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.9</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Combination Therapies 2</subfield><subfield code="b">Biological Response Modifiers in the Treatment of Cancer and Infectious Diseases</subfield><subfield code="c">edited by Enrico Garaci, Allan L. Goldstein</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Boston, MA</subfield><subfield code="b">Springer US</subfield><subfield code="c">1993</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (X, 256 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The 2nd International Symposium on Combination Therapies brought together several hundred of the leading researchers, scientists and clinicians in this area to discuss new and emerging uses for biological response modifiers (BRM's) in the treatment of cancer and infectious diseases. The meeting was held during May 1-3, 1992 in Acireale, Sicily (Italy). It was hosted by Professor G. Nicoletti CU. of Catania) and organized by the Institute for Advanced Studies in Immunology and Aging (Washington, D. C. ) in collaboration with the University of Rome "Tor Vergata," the University of Catania and The George Washington University Medical Center. The synergy exhibited between BRM's and conventional therapies including bone marrow and other lymphoid cell transplants is a rapidly expanding area with significant promise for the treatment of human diseases. Advances in this area of biomedicine are leading to the rapid development of new therapeutic approaches that are being applied clinically as both primary and adjuvant therapy to enhance the effectiveness of conventional treatments. The 2nd International Symposium on Combination Therapy provided a setting for the exchange of new scientific information regarding the emerging uses for BRM's alone or in combination with conventional therapies. The 1st International Symposium on Combination Therapies was held in 1991 in Washington, D. C.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Infectious Diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacology/Toxicology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Emerging infectious diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Toxicology</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Garaci, Enrico</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Goldstein, Allan L.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9780306445897</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781461362890</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781461529651</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-1-4615-2964-4</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031526581</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-4615-2964-4</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Konferenzschrift |
| id | DE-604.BV046146396 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:36:29Z |
| institution | BVB |
| isbn | 9781461529644 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031526581 |
| oclc_num | 1119090581 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 Online-Ressource (X, 256 p) |
| psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
| publishDate | 1993 |
| publishDateSearch | 1993 |
| publishDateSort | 1993 |
| publisher | Springer US |
| record_format | marc |
| spelling | Combination Therapies 2 Biological Response Modifiers in the Treatment of Cancer and Infectious Diseases edited by Enrico Garaci, Allan L. Goldstein Boston, MA Springer US 1993 1 Online-Ressource (X, 256 p) txt rdacontent c rdamedia cr rdacarrier The 2nd International Symposium on Combination Therapies brought together several hundred of the leading researchers, scientists and clinicians in this area to discuss new and emerging uses for biological response modifiers (BRM's) in the treatment of cancer and infectious diseases. The meeting was held during May 1-3, 1992 in Acireale, Sicily (Italy). It was hosted by Professor G. Nicoletti CU. of Catania) and organized by the Institute for Advanced Studies in Immunology and Aging (Washington, D. C. ) in collaboration with the University of Rome "Tor Vergata," the University of Catania and The George Washington University Medical Center. The synergy exhibited between BRM's and conventional therapies including bone marrow and other lymphoid cell transplants is a rapidly expanding area with significant promise for the treatment of human diseases. Advances in this area of biomedicine are leading to the rapid development of new therapeutic approaches that are being applied clinically as both primary and adjuvant therapy to enhance the effectiveness of conventional treatments. The 2nd International Symposium on Combination Therapy provided a setting for the exchange of new scientific information regarding the emerging uses for BRM's alone or in combination with conventional therapies. The 1st International Symposium on Combination Therapies was held in 1991 in Washington, D. C. Infectious Diseases Immunology Pharmacology/Toxicology Emerging infectious diseases Toxicology (DE-588)1071861417 Konferenzschrift gnd-content Garaci, Enrico edt Goldstein, Allan L. edt Erscheint auch als Druck-Ausgabe 9780306445897 Erscheint auch als Druck-Ausgabe 9781461362890 Erscheint auch als Druck-Ausgabe 9781461529651 https://doi.org/10.1007/978-1-4615-2964-4 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Combination Therapies 2 Biological Response Modifiers in the Treatment of Cancer and Infectious Diseases Infectious Diseases Immunology Pharmacology/Toxicology Emerging infectious diseases Toxicology |
| subject_GND | (DE-588)1071861417 |
| title | Combination Therapies 2 Biological Response Modifiers in the Treatment of Cancer and Infectious Diseases |
| title_auth | Combination Therapies 2 Biological Response Modifiers in the Treatment of Cancer and Infectious Diseases |
| title_exact_search | Combination Therapies 2 Biological Response Modifiers in the Treatment of Cancer and Infectious Diseases |
| title_full | Combination Therapies 2 Biological Response Modifiers in the Treatment of Cancer and Infectious Diseases edited by Enrico Garaci, Allan L. Goldstein |
| title_fullStr | Combination Therapies 2 Biological Response Modifiers in the Treatment of Cancer and Infectious Diseases edited by Enrico Garaci, Allan L. Goldstein |
| title_full_unstemmed | Combination Therapies 2 Biological Response Modifiers in the Treatment of Cancer and Infectious Diseases edited by Enrico Garaci, Allan L. Goldstein |
| title_short | Combination Therapies 2 |
| title_sort | combination therapies 2 biological response modifiers in the treatment of cancer and infectious diseases |
| title_sub | Biological Response Modifiers in the Treatment of Cancer and Infectious Diseases |
| topic | Infectious Diseases Immunology Pharmacology/Toxicology Emerging infectious diseases Toxicology |
| topic_facet | Infectious Diseases Immunology Pharmacology/Toxicology Emerging infectious diseases Toxicology Konferenzschrift |
| url | https://doi.org/10.1007/978-1-4615-2964-4 |
| work_keys_str_mv | AT garacienrico combinationtherapies2biologicalresponsemodifiersinthetreatmentofcancerandinfectiousdiseases AT goldsteinallanl combinationtherapies2biologicalresponsemodifiersinthetreatmentofcancerandinfectiousdiseases |